Benzydamine, an anti-neoplastic agent, acting as cholecystokinin antagonist Gl and brain cancers

摘要

Cholecystokinin (CCK) receptor antagonists as anticancer, analgesic, anxiolytic agents Cholecystokinin (CCK) antagonists as defined, preferably benzydamine, as anticancer agents in treating gastrointestinal cancers, in particular colon and pancreatic cancer and brain cancer.  CCK antagonists as defined, preferably benzydamine in combination with opiates, in particular morphine, to potentiate analgesia is provided.  CCK antagonists as defined, preferably benzydamine, as an antidepressant or as an anxiolytic is also provided.